跳至主要内容
临床试验/NCT02036632
NCT02036632已完成1 期

Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Change in multi-focal ERG response

研究概览

简要总结

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years of age and older
  • Both males and females
  • Patients diagnosed with active central serous retinopathy
  • Patients who are willing to use an eye patch in the affected eye for 24 hours
  • Patients who are able to make the follow up appointments as required by the study

排除标准

  • Individuals under 18 years of age
  • Patients with vision less than 20/40 in the unaffected eye.
  • Patients who are not able to undergo mfERG testing in a realiable manner.

结局指标

主要结局

Change in multi-focal ERG response

时间窗: 24 hours

Change in multi-focal ERG response and macular thickness after 24-hour patch therapy in patients with CSR

时间窗: 24 hours

This study is a prospective control trial that will compare 24-hour eye patch therapy with the current standard of care in patients with central serous retinopathy (CSR).

次要结局

  • macular thickness(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验